Asalyxa Bio logo

Asalyxa Bio

Pioneering a breakthrough in therapeutics by targeting over-reactive immune cells to address significant unmet medical needs across various disease conditions.

est. 2020

VS
Nuvig Therapeutics Inc. logo

Nuvig Therapeutics Inc.

Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases

24 employees · est. 2021 · Menlo Park, United States

Asalyxa Bio is the older company (2020 vs 2021).

Side-by-Side Comparison

Asalyxa Bio Nuvig Therapeutics Inc.
Founded
2020 older 2021
Headquarters
Not tracked yet Menlo Park, United States
Employees
Not tracked yet 24
Industry
Biotechnology Biotechnology, Health Care, Health and Wellness
Funding Stage
Seed Series A
Total Funding
$2.00M $47.00M
Funding Rounds
2 1
Services
Not tracked yet Development of Next-Generation Immunomodulators, Clinical Trials for Autoimmune Disease Therapies, Research and Development in Autoimmune Dysregulation
Target Customers
Not tracked yet Patients with Autoimmune Diseases, Healthcare Providers, Medical Researchers
Taxonomy
Therapeutics, Drug Development, Platform Technology, Immune Signaling, Targeted Delivery, Hyperactive Immune Cells, Unmet Medical Needs, Dysregulation, Novel Therapeutics, Disease Areas, Medical Conditions, Innovative Treatments, Immune Cell Targeting, Immunotherapy Immune Therapeutics, Chronic Inflammatory Diseases, Autoimmune Diseases, Immune Homeostasis, Immune Function, Inflammation, Immune System, Therapy Development, Immune Modulation, Biopharmaceuticals, Immunology, Medical Research
Website
asalyxabio.com nuvigtherapeutics.com
Asalyxa Bio logo

About Asalyxa Bio

Asalyxa Bio, a **biotechnology** startup founded in **2020**, is focused on pioneering a breakthrough in therapeutics by targeting over-reactive immune cells to address significant unmet medical needs across various disease conditions. The company's **slogan** encapsulates its mission to innovate an...

Nuvig Therapeutics Inc. logo

About Nuvig Therapeutics Inc.

Nuvig Therapeutics Inc., founded in 2021, is a pioneering player in the Biotechnology and Health Care industries. Based in the United States, the company is committed to "Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases." Nuvig Therapeutics is on a mission to develop gro...

We will tell you when either one moves

BounceWatch watches Asalyxa Bio and Nuvig Therapeutics Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Asalyxa Bio and Nuvig Therapeutics Inc... — by email.

Frequently Asked Questions

Asalyxa Bio — Pioneering a breakthrough in therapeutics by targeting over-reactive immune cells to address significant unmet medical needs across various disease conditions.. Nuvig Therapeutics Inc. — Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Asalyxa Bio has raised $2.00M while Nuvig Therapeutics Inc. has raised $47.00M.
Asalyxa Bio and Nuvig Therapeutics Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Asalyxa Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Asalyxa Bio on 12 Sep 2024, and Nuvig Therapeutics Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes